This expertly edited book offers a comprehensive exploration of the latest advancements in our understanding of age-related macular degeneration (AMD). It seamlessly combines epidemiology and clinical diagnosis with insights into genetics, immunology, proteostasis, and mitochondrial roles. The book also delves into innovative therapies, including stem cell-based approaches.
AMD is a leading cause of largely incurable blindness worldwide, with cases projected to double from 2.07 million to 5.44 million in the United States by 2050. Globally, 288 million individuals are expected to be affected by 2040. The disease’s impact is profound, affecting not only individuals but also their families and society at large. This book bridges state-of-the-art basic science with clinically relevant findings, addressing future research challenges in AMD.
By intersecting various disciplines, this resource uncovers potential areas for further investigation, aiming to reduce the burden of blindness caused by AMD. It is an appealing and insightful resource for clinicians, scientists, students, and fellows who seek a deeper understanding of this critical topic.
- What is this book about? – A thorough examination of AMD, combining science and clinical insights.
- Who should read it? – Clinicians, scientists, students, and fellows in the field of ophthalmology and related disciplines.
- What makes it special? – An intersection of diverse disciplines to foster future research and innovation.
Unlock the potential for groundbreaking research and therapy with this essential resource on AMD.</p
Authors:
Emily Y. Chew (Editor)
Edition:
1st ed. 2021
Publication Date:
April 13, 2021
Reviews
There are no reviews yet.